CIK 0001472091
- Non-accelerated filer
- Smaller reporting company
PDS Biotechnology Corp
Sign in to watch- Ticker
- PDSB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 264231384
- Phone
- +1 800-208-3343
- Business address
- 303A COLLEGE ROAD EAST, PRINCETON, NJ, 08540
- Former names
- Edge Therapeutics, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-01-05 | HILL MATTHEW C Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +161,200 | 161,200 | ||
| 2021-12-13 | HILL MATTHEW C Chief Financial Officer | Purchase | +2,500 | $9.00 | $23K | 3,475 |
| 2021-12-13 | HILL MATTHEW C Chief Financial Officer | Purchase | +400 | $8.90 | $4K | 3,875 |
| 2021-12-13 | HILL MATTHEW C Chief Financial Officer | Purchase | +100 | $9.00 | $900 | 3,975 |
| 2021-12-13 | HILL MATTHEW C Chief Financial Officer | Purchase | +100 | $9.00 | $900 | 4,075 |
| 2021-10-19 | HILL MATTHEW C Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +202,800 | 202,800 |
Page 1 of 1 · 6 trades